P. Violi

Long‐term sequential deferiprone–deferoxamine versus deferiprone alone for thalassaemia major patients: a randomized clinical trial

G. D’Amico, A. Morabito, C. Gluud, 2009, British journal of haematology.

Sequential Alternating Deferiprone And Deferoxamine Treatment Compared To Deferiprone Monotherapy: Main Findings And Clinical Follow-Up Of A Large Multicenter Randomized Clinical Trial In -Thalassemia Major Patients

G. D’Amico, A. Morabito, C. Gluud, 2011, Hemoglobin.

Improving survival with deferiprone treatment in patients with thalassemia major: a prospective multicenter randomised clinical trial under the auspices of the Italian Society for Thalassemia and Hemoglobinopathies.

P. Cianciulli, L. Cuccia, V. Caruso, 2009, Blood cells, molecules & diseases.

Deferiprone Versus Sequential Deferiprone-Deferoxamine Treatment in Thalassemia Major: A Five Years Multicenter Randomized Clinical Trial under the Auspices of the Society for the Study of Thalassemia and Hemoglobinopathies (SoSTE).

G. D’Amico, A. Morabito, P. Cianciulli, 2007 .

1170 IL28B C/C POLYMORPHISM IS PREDICTIVE OF SPONTANEOUS HCV RNA CLEARANCE IN PATIENTS WITH THALASSEMIA MAJOR

A. Andriulli, A. Mangia, L. Mottola, 2010 .